Amidine and isothiourea derivatives as inhibitors of nitric oxide
申请人:Astra Aktiebolag
公开号:US06140322A1
公开(公告)日:2000-10-31
There are provided novel compounds of formula (I) ##STR1## wherein X, R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are as defined in the specification and optical isomers and racemates thereof and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy.
AMIDINE AND ISOTHIOUREA DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHASE
申请人:AstraZeneca AB
公开号:EP0861250B1
公开(公告)日:2002-02-13
US5929085A
申请人:——
公开号:US5929085A
公开(公告)日:1999-07-27
US6140322A
申请人:——
公开号:US6140322A
公开(公告)日:2000-10-31
Probes of the active site of norepinephrine N-methyltransferase: effect of hydrophobic and hydrophilic interactions on side-chain binding of amphetamine and .alpha.-methylbenzylamine
作者:Gary L. Grunewald、James Monn、Michael F. Rafferty、Ronald T. Borchardt、Polina Krass
DOI:10.1021/jm00352a031
日期:1982.10
ine were prepared and evaluated as inhibitors of norepinephrine N-methyltransferase (NMT). These included several alkyl side chain extended analogues (1-5), as well as the terminally hydroxylated derivatives phenylalanol (6a) and phenylglycinol (7a). None of the alkyl-substituted derivatives displayed appreciable activity as inhibitors; however, the hydroxylated analogues were up to twofold more potent